Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Validation of consensus panel diagnosis in dementia.

Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY.

Arch Neurol. 2010 Dec;67(12):1506-12. doi: 10.1001/archneurol.2010.301.

2.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL.

Arch Neurol. 2011 Mar;68(3):329-37. doi: 10.1001/archneurol.2010.295. Epub 2010 Nov 8.

3.

Occupation attributes relate to location of atrophy in frontotemporal lobar degeneration.

Spreng RN, Rosen HJ, Strother S, Chow TW, Diehl-Schmid J, Freedman M, Graff-Radford NR, Hodges JR, Lipton AM, Mendez MF, Morelli SA, Black SE, Miller BL, Levine B.

Neuropsychologia. 2010 Oct;48(12):3634-41. doi: 10.1016/j.neuropsychologia.2010.08.020. Epub 2010 Aug 26.

4.

An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration.

Boxer AL, Lipton AM, Womack K, Merrilees J, Neuhaus J, Pavlic D, Gandhi A, Red D, Martin-Cook K, Svetlik D, Miller BL.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):211-7. doi: 10.1097/WAD.0b013e318197852f.

5.

Clinical aspects of hippocampal sclerosis.

Leverenz JB, Lipton AM.

Handb Clin Neurol. 2008;89:565-7. doi: 10.1016/S0072-9752(07)01252-3. No abstract available.

PMID:
18631778
6.

Reduced hippocampal functional connectivity in Alzheimer disease.

Allen G, Barnard H, McColl R, Hester AL, Fields JA, Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM.

Arch Neurol. 2007 Oct;64(10):1482-7.

PMID:
17923631
7.

MMSE scores decline at a greater rate in frontotemporal degeneration than in AD.

Chow TW, Hynan LS, Lipton AM.

Dement Geriatr Cogn Disord. 2006;22(3):194-9. Epub 2006 Aug 7.

8.

Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.

Bhargava D, Weiner MF, Hynan LS, Diaz-Arrastia R, Lipton AM.

J Geriatr Psychiatry Neurol. 2006 Jun;19(2):78-82.

PMID:
16690992
9.

Convergence of connected language and SPECT in variants of frontotemporal lobar degeneration.

Chapman SB, Bonte FJ, Wong SB, Zientz JN, Hynan LS, Harris TS, Gorman AR, Roney CA, Lipton AM.

Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):202-13. Erratum in: Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):125.

PMID:
16327347
10.

Subscores of the FAB differentiate frontotemporal lobar degeneration from AD.

Lipton AM, Ohman KA, Womack KB, Hynan LS, Ninman ET, Lacritz LH.

Neurology. 2005 Sep 13;65(5):726-31.

PMID:
16157906
11.

Rate of progression differs in frontotemporal dementia and Alzheimer disease.

Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D.

Neurology. 2005 Aug 9;65(3):397-403.

PMID:
16087904
12.

Referral patterns for syndromes associated with frontotemporal lobar degeneration.

Chow TW, Hodges JR, Dawson KE, Miller BL, Smith V, Mendez MF, Lipton AM; National Alzheimer's Coordinating Center.

Alzheimer Dis Assoc Disord. 2005 Jan-Mar;19(1):17-9.

13.

Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.

Lipton AM, White CL 3rd, Bigio EH.

Acta Neuropathol. 2004 Nov;108(5):379-85. Epub 2004 Sep 4.

PMID:
15351890
14.

Lateralization on neuroimaging does not differentiate frontotemporal lobar degeneration from Alzheimer's disease.

Lipton AM, Benavides R, Hynan LS, Bonte FJ, Harris TS, White CL 3rd, Bigio EH.

Dement Geriatr Cogn Disord. 2004;17(4):324-7.

PMID:
15178946
15.

Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically?

Weiner MF, Hynan LS, Parikh B, Zaki N, White CL 3rd, Bigio EH, Lipton AM, Martin-Cook K, Svetlik DA, Cullum CM, Vobach S, Rosenberg RN.

J Geriatr Psychiatry Neurol. 2003 Dec;16(4):245-50.

PMID:
14653435
16.

Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS.

Bigio EH, Lipton AM, White CL 3rd, Dickson DW, Hirano A.

Neuropathol Appl Neurobiol. 2003 Jun;29(3):239-53.

PMID:
12787321
17.

Differential activation on fMRI of monozygotic twins discordant for AD.

Lipton AM, McColl R, Cullum CM, Allen G, Ringe WK, Bonte FJ, McDonald E, Rubin CD.

Neurology. 2003 May 27;60(10):1713-6.

PMID:
12771278
18.

Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.

Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, Svetlik D.

Arch Neurol. 2003 Apr;60(4):510-5.

PMID:
12707064
19.

Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias.

Lipton AM, Cullum CM, Satumtira S, Sontag E, Hynan LS, White CL 3rd, Bigio EH.

Arch Neurol. 2001 Aug;58(8):1233-9.

PMID:
11493163
20.

Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia.

Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, Nacharaju P, White CL 3rd, Davies P, Lin W, Dickson DW.

J Neuropathol Exp Neurol. 2001 Apr;60(4):328-41.

PMID:
11305868

Supplemental Content

Loading ...
Support Center